Two polymorphisms (rs699947, rs2010963) in the VEGFA gene and diabetic retinopathy: An updated meta-analysis

BMC Ophthalmology

Volumn 13, Issue 1, 2013, Pages

  Lu, Yan ^a   Ge, Yirui ^a   Shi, Yuhua ^a   Yin, Jie ^a   Huang, Zhenping ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

Diabetic retinopathy; Meta analysis; Polymorphism; The vascular endothelial growth factor gene

Indexed keywords

VASCULOTROPIN A;

ARTICLE; CASE CONTROL STUDY; DIABETIC RETINOPATHY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HUMAN; META ANALYSIS; RISK;

CASE-CONTROL STUDIES; DIABETIC RETINOPATHY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ODDS RATIO; POLYMORPHISM, GENETIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84885456036     PISSN: None     EISSN: 14712415     Source Type: Journal    
DOI: 10.1186/1471-2415-13-56     Document Type: Article

References (36)

1. Retinopathy in diabetes. Fong DS, Aiello L, Gardner TW, King GL, Blankenship G, Cavallerano JD, et al. Diabetes Care 2004 271 84 87
2. The role of genetics in susceptibility to diabetic retinopathy. Liew G, Klein R, Wong TY, Int Ophthalmol Clin 2009 49 35 52
3. Vascular endothelial growth factor and diabetic complications. Wirostko B, Wong TY, Simo R, Prog Retin Eye Res 2008 27 608 621 10.1016/j.preteyeres. 2008.09.002 18929676
4. VEGF-initiated blood-retinal barrier breakdown in early diabetes. Qaum T, Xu Q, Joussen AM, Clemens MW, Qin W, Miyamoto K, et al. Invest Ophthalmol Vis Sci 2001 42 2408 2413 11527957 (Pubitemid 32848873)
5. Polymorphisms of the vascular endothelial growth factor and susceptibility to diabetic microvascular complications in patients with type 1 diabetes mellitus. Yang B, Cross DF, Ollerenshaw M, Millward BA, Demaine AG, J Diabetes Complications 2003 17 1 6 12505748 (Pubitemid 36042784)
6. Functional VEGF C-634G polymorphism is associated with development of diabetic macular edema and correlated with macular retinal thickness in type 2 diabetes. Awata T, Kurihara S, Takata N, Neda T, Iizuka H, Ohkubo T, et al. Biochem Biophys Res Commun 2005 333 679 685 10.1016/j.bbrc.2005.05.167 15963467 (Pubitemid 40854214)
7. Association of the VEGF gene polymorphism with diabetic retinopathy in type 2 diabetes patients. Buraczynska M, Ksiazek P, Baranowicz-Gaszczyk I, Jozwiak L, Nephrol Dial Transplant 2007 22 827 832 10.1093/ndt/gfl641 17121786 (Pubitemid 46351692)
8. Common sequence variation in the VEGFA gene predicts risk of diabetic retinopathy. Abhary S, Burdon KP, Gupta A, Lake S, Selva D, Petrovsky N, et al. Invest Ophthalmol Vis Sci 2009 50 5552 5558 10.1167/iovs.09-3694 19553626
9. Impact of variants in the VEGF gene on progression of proliferative diabetic retinopathy. Nakamura S, Iwasaki N, Funatsu H, Kitano S, Iwamoto Y, Graefes Arch Clin Exp Ophthalmol 2009 247 21 26 10.1007/s00417-008-0915-3 18709380
10. Association of vascular endothelial growth factor polymorphisms with nonproliferative and proliferative diabetic retinopathy. Chun MY, Hwang HS, Cho HY, Chun HJ, Woo JT, Lee KW, et al. J Clin Endocrinol Metab 2010 95 3547 3551 10.1210/jc.2009-2719 20444917
11. Polymorphisms in the vascular endothelial growth factor gene and the risk of diabetic retinopathy in Chinese patients with type 2 diabetes. Yang X, Deng Y, Gu H, Lim A, Altankhuyag A, Jia W, et al. Mol Vis 2011 17 3088 3096 22162628
12. Functional vascular endothelial growth factor -634G > C SNP is associated with proliferative diabetic retinopathy: a case-control study in a Brazilian population of European ancestry. Errera FI, Canani LH, Silva ME, Yeh E, Takahashi W, Santos KG, et al. Diabetes Care 2007 30 275 279 10.2337/dc06-1399 17259494 (Pubitemid 46198330)
13. Local and genetic determinants of vascular endothelial growth factor expression in advanced proliferative diabetic retinopathy. Petrovic MG, Korosec P, Kosnik M, Osredkar J, Hawlina M, Peterlin B, et al. Mol Vis 2008 14 1382 1387 18682813
14. Association of VEGF gene polymorphisms with diabetic retinopathy in a south Indian cohort. Uthra S, Raman R, Mukesh BN, Rajkumar SA, Padmaja KR, Paul PG, et al. Ophthalmic Genet 2008 29 11 15 10.1080/13816810701663527 18363167 (Pubitemid 351431242)
15. Polymorphism of the manganese superoxide dismutase gene but not of vascular endothelial growth factor gene is a risk factor for diabetic retinopathy. Kangas-Kontio T, Vavuli S, Kakko SJ, Penna J, Savolainen ER, Savolainen MJ, et al. Br J Ophthalmol 2009 93 1401 1406 10.1136/bjo.2009.159012 19628492
16. Relationship of vascular endothelial growth factor (VEGF) +405 G/C polymorphism and proliferative retinopathy in patients with type 2 diabetes. Feghhi M, Nikzamir A, Esteghamati A, Mahmoudi T, Yekaninejad MS, Transl Res 2011 158 85 91 10.1016/j.trsl.2011.03.002 21757152
17. A systematic meta-analysis of genetic association studies for diabetic retinopathy. Abhary S, Hewitt AW, Burdon KP, Craig JE, Diabetes 2009 58 2137 2147 10.2337/db09-0059 19587357
18. Association between the -634C/G polymorphisms of the vascular endothelial growth factor and retinopathy in type 2 diabetes: a meta-analysis. Zhao T, Zhao J, Diabetes Res Clin Pract 2010 90 45 53 10.1016/j.diabres.2010.05.029 20591524
19. VEGF -634G > C polymorphism and diabetic retinopathy risk: a meta-analysis. Qiu M, Xiong W, Liao H, Li F, Gene 2013 518 310 315 10.1016/j.gene.2013.01.018 23353010
20. Association of vascular endothelial growth factor -634C/G polymorphism and diabetic retinopathy in type 2 diabetic Han Chinese. Yang Y, Andresen BT, Yang K, Zhang Y, Li X, Li X, et al. Exp Biol Med (Maywood) 2010 235 1204 1211 10.1258/ebm.2010.010102 20801867
21. Meta-analysis in clinical trials. DerSimonian R, Laird N, Control Clin Trials 1986 7 177 188 10.1016/0197-2456(86)90046-2 3802833 (Pubitemid 17189972)
22. Statistical aspects of the analysis of data from retrospective studies of disease. Mantel N, Haenszel W, J Natl Cancer Inst 1959 22 719 748 13655060
23. Operating characteristics of a rank correlation test for publication bias. Begg CB, Mazumdar M, Biometrics 1994 50 1088 1101 10.2307/2533446 7786990
24. Bias in meta-analysis detected by a simple, graphical test. Egger M, Davey Smith G, Schneider M, Minder C, BMJ 1997 315 629 634 10.1136/bmj.315.7109. 629 9310563 (Pubitemid 27387172)
25. The pathogenesis of early retinal changes of diabetic retinopathy. Arden GB, Sivaprasad S, Doc Ophthalmol 2012 124 15 26 10.1007/s10633-011-9305-y 22302291
26. Role of the VEGF 936 C/T polymorphism in diabetic microvascular complications in type 2 diabetic patients. Kim HW, Ko GJ, Kang YS, Lee MH, Song HK, Kim HK, et al. Nephrology (Carlton) 2009 14 681 688 10.1111/j.1440-1797. 2009.01085.x 19796028
27. Association of vascular endothelial growth factor, transforming growth factor beta, and interferon gamma gene polymorphisms with proliferative diabetic retinopathy in patients with type 2 diabetes. Paine SK, Basu A, Mondal LK, Sen A, Choudhuri S, Chowdhury IH, et al. Mol Vis 2012 18 2749 2757 23213275
28. What is the contribution of two genetic variants regulating VEGF levels to type 2 diabetes risk and to microvascular complications? Bonnefond A, Saulnier PJ, Stathopoulou MG, Grarup N, Ndiaye NC, Roussel R, et al. PLoS One 2013 8 55921 10.1371/journal.pone.0055921 23405237
29. A common polymorphism in the 5′-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Awata T, Inoue K, Kurihara S, Ohkubo T, Watanabe M, Inukai K, et al. Diabetes 2002 51 1635 1639 10.2337/diabetes.51.5.1635 11978667 (Pubitemid 34826636)
30. Single nucleotide polymorphisms of vascular endothelial growth factor gene intron 2 are markers for early progression of diabetic retinopathy in Japanese with type 1 diabetes. Nakanishi K, Watanabe C, Clin Chim Acta 2009 402 171 175 10.1016/j.cca.2009.01.004 19263526
31. VEGF polymorphisms are associated with severity of diabetic retinopathy. Churchill AJ, Carter JG, Ramsden C, Turner SJ, Yeung A, Brenchley PE, et al. Invest Ophthalmol Vis Sci 2008 49 3611 3616 10.1167/iovs.07-1383 18441306
32. Multiple variants in vascular endothelial growth factor (VEGFA) are risk factors for time to severe retinopathy in type 1 diabetes: the DCCT/EDIC genetics study. Al-Kateb H, Mirea L, Xie X, Sun L, Liu M, Chen H, et al. Diabetes 2007 56 2161 2168 10.2337/db07-0376 17513698 (Pubitemid 47195838)
33. Association of the VEGF gene with proliferative diabetic retinopathy but not proteinuria in diabetes. Ray D, Mishra M, Ralph S, Read I, Davies R, Brenchley P, Diabetes 2004 53 861 864 10.2337/diabetes.53.3.861 14988276 (Pubitemid 38270661)
34. Association of VEGF and eNOS gene polymorphisms in type 2 diabetic retinopathy. Suganthalakshmi B, Anand R, Kim R, Mahalakshmi R, Karthikprakash S, Namperumalsamy P, et al. Mol Vis 2006 12 336 341 16636650
35. An association between vascular endothelial growth factor gene promoter polymorphisms and diabetic retinopathy. Szaflik JP, Wysocki T, Kowalski M, Majsterek I, Borucka AI, Blasiak J, et al. Graefes Arch Clin Exp Ophthalmol 2008 246 39 43 17849138 (Pubitemid 350162682)
36. Erythropoietin is highly elevated in vitreous fluid of patients with proliferative diabetic retinopathy. Katsura Y, Okano T, Matsuno K, Osako M, Kure M, Watanabe T, et al. Diabetes Care 2005 28 2252 2254 10.2337/diacare.28.9.2252 16123502 (Pubitemid 41242480)